Korro Bio is trading 10.12% down at $12.43 after no confirmed company-specific announcement was identified for September 17, 2026.
- The latest company filing reported September 11 inducement grants to three employees covering 5,000 stock options, but did not clearly explain today’s decline.
- Biotechnology is rallying, with XBI up 2.55%, leaving Korro Bio’s sharp drop unexplained and contrary to broader sector strength.